Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device

A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma

NCT00277498 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP

NCT03318146 ·Status: UNKNOWN ·Phase: NA

A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma

NCT00159653 ·Status: COMPLETED ·Phase: PHASE3

Adjunctive Study of AL-37807 Ophthalmic Suspension

NCT00620256 ·Status: COMPLETED ·Phase: PHASE2

Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom

NCT01012245 ·Status: COMPLETED

A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension

NCT01379144 ·Status: COMPLETED ·Phase: PHASE2

Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT00465621 ·Status: COMPLETED ·Phase: PHASE2

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00287521 ·Status: COMPLETED ·Phase: PHASE2

A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG

NCT01037036 ·Status: COMPLETED ·Phase: PHASE2

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00293787 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin

NCT00759941 ·Status: COMPLETED ·Phase: PHASE4

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00293800 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients

NCT02278614 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).

NCT00383019 ·Status: COMPLETED ·Phase: PHASE3

Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma

NCT01209624 ·Status: COMPLETED

Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure

NCT00230763 ·Status: COMPLETED ·Phase: PHASE3

Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension

NCT00219596 ·Status: COMPLETED ·Phase: PHASE3

Cosopt Versus Xalatan

NCT00273429 ·Status: COMPLETED ·Phase: PHASE4

A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma

NCT00140049 ·Status: COMPLETED ·Phase: PHASE4

A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

NCT00527592 ·Status: COMPLETED ·Phase: PHASE4

A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT04133311 ·Status: COMPLETED ·Phase: PHASE3

Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®

NCT00799682 ·Status: COMPLETED ·Phase: PHASE4

Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN

NCT00798759 ·Status: COMPLETED ·Phase: PHASE4

Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health

NCT00892762 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma

NCT02792803 ·Status: UNKNOWN ·Phase: PHASE4